Published Date: 17 Feb 2023
For people previously infected with COVID-19, analysis and assessment showed an 88% lower rate of hospitalization or death for at least 10 months compared to people who had no pre-existing disease .
Read Full NewsResearchers seek to understand why Asian women fare better with the disease.
By carefully controlling the mix of stem and T cells, Orca‑T lowers the risk for graft-vs-host disease in adults with hematologic cancers.
1.
Worse Outcomes After Esophagectomy at Private Equity-Owned Hospitals
2.
How AI will transform mental health support for patients with breast cancer
3.
'It's rare and it's scary.' Dark spot on your fingernail could mean cancer
4.
In heavily pretreated DLBCL, Triplet Scores a Survival Victory.
5.
Breast cancer prevention: How nurse practitioners and physician assistants can help
1.
Transplant Oncology and Anti-Cancer Immunosuppressants: The Evolution of a Paradigm in Cancer Care
2.
Emerging Insights in Hematology for Better Care
3.
Survival Rate Dynamics in Hematologic and Solid Malignancies
4.
Unlocking the Potential of Lutathera: A Revolutionary Cancer Treatment
5.
Revolutionizing Cancer Treatment with Mercaptopurine: A New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
3.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part IV
5.
Navigating the Complexities of Ph Negative ALL - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation